Molecular evolution and binding free energy analysis of substrates of cephalosporinase ADC-57

( views:234, downloads:0 )
Author:
ZHOU Jun(Department of Respiratory Medicine, the First People' s Hospital of Changzhou, Changzhou 213003, Jiangsu Province, China)
WANG Yu-yue()
ZHANG Qiu-di(Department of Respiratory Medicine, the First People' s Hospital of Changzhou, Changzhou 213003, Jiangsu Province, China)
Journal Title:
Chinese Journal of Clinical Infectious Diseases
Issue:
Volume 05, Issue 02, 2012
DOI:
10.3760/cma.j.issn.1674-2397.2012.02.004
Key Word:
Beta-lactams;Cephalosporinase;Evolution, molecular;Molecular docking;Binding free energy

Abstract: Objective To analyze molecular evolution and binding free energies of cephalosporinase ADC-57.Methods Minimum Evolution method in MEGA 5.0 was used to analyze molecular evolution of cephalosporinase ADC-57 and other 19 kinds of beta-lactamases.Tertiary structure of ADC-57 was predicted by homology modeling referring to tertiary structure of CMY-2.The molecular docking of ADC-57 to 11kinds of beta-lactams substrates was performed using DOCK module in ArgusLab 4.1and the binding free energies (△G) was calculated.Results ADC-57,CMY-2,DHA-1,ADC-7,ADC-56 were all belong to class C beta-lactamase,and molecular evolution between ADC-57 and ADC-56 was closest.The top three antibiotics with declining binding free energy of beta-lactams were ertapenem,cefoxitin and ceftazidine,while the last two were clavulanic acid and aztreonam.Conclusions Catalytic activities of cephalosporinase ADC-57 to ertapenem,cefoxitin and ceftazidine are high,while to clavulanic acid and aztreonam are low. Hydrolytic activities of enzyme to beta-lactams (substrates) can be analyzed by molecular docking.

  • [1]Hujer KM,Hamza NS,Hujer AM,et al.Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase,ADC-7 beta-lactamase: defining a unique family of class C enzymes.Antimicrob Agents Chemother,2005,49 (7):2941-2948.
  • [2]糜祖煌,翁幸鐾,秦玲.KPC型碳青霉烯酶分子进化及与底物结合自由能分析.中华临床感染病杂志,2010,3(3):134-137.
  • [3]Philippon A,Arlet G,Jacoby GA.Plasmid-determined AmpC-type beta-lactamases.Antimicrob Agents Chemother.2002,46 (1):1-11.
  • [4]Jacoby GA..AmpC beta-lactamases.Clin Microbiol Rev,2009,22(1):161-182.
  • [5]Munoz-Price LS,Weinstein RA.Acinetobacter Infection.N Engl J Med,2008,358(12):1271-1281.
  • [6]Peleg AY,Seifert H,Paterson DL.Acinetobacter baumannii:emergence of a successful pathogen.Clin Microbiol Rev,2008,21(3):538-582.
  • [7]Kuo LC,Teng LJ,Yu C J,et al.Dissemination of a clone of unusual phenotype of pandrug-resistant Acinetobacter baumannii at a University Hospital in Taiwan.J Clin Microbiol,2004,42 (4):1759-1763.
  • [8]Park YK,Peck KR,Cheong HS,et al.Extreme drug resistance in Acinetobacter baumannii infections in intensive care units,South Korea.Emerg Infect Dis,2009,15 (8):1325-1326.
  • [9]Héritier C,Poirel L,Nordmann P.Cephalosporinase over-expression resulting from insertion of ISAbal in Acinetobacter baumannii.Clin Microbiol Infect,2006,12 (2):123-130.
  • [10]Figueiredo S,Poirel L,Croize J,et al.In vivo selection of reduced susceptibility to carbapenems in Acinetobacter baumannii related to ISAbal-mediated overexpression of the natural bla (OXA-66)oxacillinase Gene.Antimicrob Agents Chemother,2009,53 (6):2657-2659.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn